Colesevelam hydrochloride
NDC 27808-190, Colesevelam hydrochloride, tablet, from Cranbury Pharmaceuticals, LLC.
- Product NDC
- 27808-190
- Status
- Listed
- Labeler
- Cranbury Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209946
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27808-190 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- COLESEVELAM HYDROCHLORIDE625 mg/1
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27808-190-01 | 27808019001 | 180 TABLET in 1 BOTTLE (27808-190-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5e50cc0c-03bc-444b-9d15-ea112bc0f91cNADAC price for package 27808019001
GET /v1/drugs/nadac/27808019001
Use it
Look up 27808-190 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27808-190 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27808-190. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.